Among other differences from FDA-approved drug products, compounded drug products have not undergone FDA premarket review for safety, effectiveness, or quality
503A compounding for individual patients continues when the prescriber documents specific clinical need that isnt met by the FDA-approved product
Clin Gastroenterol Hepatol 2025;23:20832085.ArticlePubMed 12
The good news from the study is that patients experienced improvements in blood pressure, total cholesterol level and HbA1c level, underscoring the products association with prevention of cardiovascular disease risks
For 90% of patients, going off of a GLP-1 usually means rapid regaining of lost weight and reversal of health benefits
These studies should also be extended to other nuclei throughout the neuraxis, including those in hypothalamic and mesolimbic reward areas